MedTrace Logo

Programming by Estrogen Treatment in Gonadotropin Releasing Hormone Antagonist Protocol

NCT01419353 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2013-12-24

No results posted yet for this study

Summary

The purpose of this study is to determine if pretreatment with Estrogen can assist in the planning and programming of In Vitro Fertilization treatments.

Conditions

Interventions

DRUG

estradiol valerate

2 mg P.O / day for 1-6 days.

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Principal Investigators

  • Adrian Shulman, MD · Meir Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
38 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01419353 on ClinicalTrials.gov